CAD 0.06
(-7.69%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.03 CAD | 26.72% |
2022 | -0.04 CAD | 80.35% |
2021 | -0.20 CAD | -507.9% |
2020 | -0.03 CAD | -174.17% |
2019 | -0.01 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.00 CAD | 49.43% |
2024 Q2 | -0.00 CAD | 13.64% |
2023 Q1 | -0.01 CAD | 52.52% |
2023 FY | - CAD | 26.72% |
2023 Q4 | -0.01 CAD | -35.94% |
2023 Q3 | -0.01 CAD | 7.25% |
2023 Q2 | -0.01 CAD | -4.55% |
2022 Q2 | -0.01 CAD | 14.29% |
2022 FY | - CAD | 80.35% |
2022 Q1 | -0.01 CAD | -131.53% |
2022 Q4 | -0.01 CAD | -157.41% |
2022 Q3 | -0.01 CAD | 40.0% |
2021 Q4 | 0.03 CAD | 516.25% |
2021 FY | - CAD | -507.9% |
2021 Q1 | -0.52 CAD | -104100.0% |
2021 Q2 | -0.02 CAD | 96.02% |
2021 Q3 | -0.01 CAD | 61.35% |
2020 FY | - CAD | -174.17% |
2020 Q4 | 0.00 CAD | 133.33% |
2020 Q3 | -0.00 CAD | -114.29% |
2020 Q2 | -0.00 CAD | 0.0% |
2020 Q1 | -0.00 CAD | -75.0% |
2019 Q4 | -0.00 CAD | 33.33% |
2019 Q2 | 0.00 CAD | 200.0% |
2019 Q3 | -0.00 CAD | -250.0% |
2019 Q1 | -0.00 CAD | 0.0% |
2019 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 93.6% |
Asep Medical Holdings Inc | -0.13 CAD | 77.846% |
BetterLife Pharma Inc. | -0.03 CAD | -9.091% |
BioVaxys Technology Corp. | -0.06 CAD | 49.738% |
ChitogenX Inc. | -0.02 CAD | -35.211% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | 29.756% |
Defence Therapeutics Inc. | -0.30 CAD | 90.4% |
Entheon Biomedical Corp. | -0.05 CAD | 43.307% |
Gemina Laboratories Ltd. | -0.07 CAD | 60.0% |
Lexston Life Sciences Corp. | -0.02 CAD | -25.217% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | -213.043% |
Doseology Sciences Inc. | -0.08 CAD | 63.864% |
MYND Life Sciences Inc. | -0.03 CAD | 10.28% |
Nova Mentis Life Science Corp. | -0.01 CAD | -246.988% |
PharmaTher Holdings Ltd. | -0.04 CAD | 18.414% |
PreveCeutical Medical Inc. | -0.00 CAD | -1100.0% |
Telescope Innovations Corp. | -0.12 CAD | 76.0% |